Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Peak sales projections for orforglipron hover around $15B annuallya figure eclipsed by tirzepatide, which recorded $10B in actual revenue in 3Q25 alone
Most people start by eating better and moving more, but sometimes, thats not enough
Pharmaceutical Benefits Scheme (PBS) The PBS is the vehicle by which the government subsidises the cost of medicine for most medical conditions
The FDA is reconsidering its 2023 ban on certain injectable peptides with advisory review starting in July, opening the door to compounding if cleared
Such hyperandrogenemia has a deleterious impact on ovulation and metabolic function, promoting adiposity and insulin resistance 5
increased awareness of gut health and hormonal regulation
US$ 26.94
US$ 22.66
US$ 26.38
